Literature DB >> 17330044

Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum.

Heather J Painter1, Joanne M Morrisey, Michael W Mather, Akhil B Vaidya.   

Abstract

The origin of all mitochondria can be traced to the symbiotic arrangement that resulted in the emergence of eukaryotes in a world that was exclusively populated by prokaryotes. This arrangement, however, has been in continuous genetic flux: the varying degrees of gene loss and transfer from the mitochondrial genome in different eukaryotic lineages seem to signify an ongoing 'conflict' between the host and the symbiont. Eukaryotic parasites belonging to the phylum Apicomplexa provide an excellent example to support this view. These organisms contain the smallest mitochondrial genomes known, with an organization that differs among various genera; one genus, Cryptosporidium, seems to have lost the entire mitochondrial genome. Here we show that erythrocytic stages of the human malaria parasite Plasmodium falciparum seem to maintain an active mitochondrial electron transport chain to serve just one metabolic function: regeneration of ubiquinone required as the electron acceptor for dihydroorotate dehydrogenase, an essential enzyme for pyrimidine biosynthesis. Transgenic P. falciparum parasites expressing Saccharomyces cerevisiae dihydroorotate dehydrogenase, which does not require ubiquinone as an electron acceptor, were completely resistant to inhibitors of mitochondrial electron transport. Maintenance of mitochondrial membrane potential, however, was essential in these parasites, as indicated by their hypersensitivity to proguanil, a drug that collapsed the membrane potential in the presence of electron transport inhibitors. Thus, acquisition of just one enzyme can render mitochondrial electron transport nonessential in erythrocytic stages of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330044     DOI: 10.1038/nature05572

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  194 in total

Review 1.  Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.

Authors:  Benjamin Blasco; Didier Leroy; David A Fidock
Journal:  Nat Med       Date:  2017-08-04       Impact factor: 53.440

Review 2.  Biochemistry and evolution of anaerobic energy metabolism in eukaryotes.

Authors:  Miklós Müller; Marek Mentel; Jaap J van Hellemond; Katrin Henze; Christian Woehle; Sven B Gould; Re-Young Yu; Mark van der Giezen; Aloysius G M Tielens; William F Martin
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Mitochondrial RNA polymerase is an essential enzyme in erythrocytic stages of Plasmodium falciparum.

Authors:  Hangjun Ke; Joanne M Morrisey; Suresh M Ganesan; Michael W Mather; Akhil B Vaidya
Journal:  Mol Biochem Parasitol       Date:  2012-05-26       Impact factor: 1.759

4.  Combining Inhibitor Resistance-conferring Mutations in Cytochrome b Creates Conditional Synthetic Lethality in Saccharomyces cerevisiae.

Authors:  Martina G Ding; Jean-Paul di Rago; Bernard L Trumpower
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

5.  Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.

Authors:  Erik L Allman; Heather J Painter; Jasmeet Samra; Manuela Carrasquilla; Manuel Llinás
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.

Authors:  Changbo Qu; Shaoshi Zhang; Wenshi Wang; Meng Li; Yijin Wang; Marieke van der Heijde-Mulder; Ehsan Shokrollahi; Mohamad S Hakim; Nicolaas J H Raat; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  FASEB J       Date:  2018-08-02       Impact factor: 5.191

7.  Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria.

Authors:  Sreekanth Kokkonda; Xiaoyi Deng; Karen L White; Farah El Mazouni; John White; David M Shackleford; Kasiram Katneni; Francis C K Chiu; Helena Barker; Jenna McLaren; Elly Crighton; Gong Chen; Inigo Angulo-Barturen; Maria Belen Jimenez-Diaz; Santiago Ferrer; Leticia Huertas-Valentin; Maria Santos Martinez-Martinez; Maria Jose Lafuente-Monasterio; Rajesh Chittimalla; Shatrughan P Shahi; Sergio Wittlin; David Waterson; Jeremy N Burrows; Dave Matthews; Diana Tomchick; Pradipsinh K Rathod; Michael J Palmer; Susan A Charman; Margaret A Phillips
Journal:  J Med Chem       Date:  2020-04-16       Impact factor: 7.446

8.  Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Alka Marwaha; Farah El Mazouni; John White; Karen L White; Sharon Creason; David M Shackleford; Jeffrey Baldwin; William N Charman; Frederick S Buckner; Susan Charman; Pradipsinh K Rathod; Margaret A Phillips
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

9.  Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum.

Authors:  Ruth Howe; Megan Kelly; John Jimah; Dana Hodge; Audrey R Odom
Journal:  Eukaryot Cell       Date:  2012-12-07

10.  Genetic identification of essential indels and domains in carbamoyl phosphate synthetase II of Toxoplasma gondii.

Authors:  Barbara A Fox; Jessica G Ristuccia; David J Bzik
Journal:  Int J Parasitol       Date:  2008-10-21       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.